A. M. Pappas & Associates is gearing up to raise $25 million for an investment fund that would target small, publicly traded life sciences companies nationwide and. The fund is called Emerging Life Science Equities III. In June, the Research Triangle-based firm closed a $102 million fund, called TechAmp II, targeted at life science startups. www.ampappas.com
CED News
« AGTC Announces $6 M Phase One Investment | Main | Wake Forest and Virginia Tech Join Forces in Biomedical Engineering »